Hallermann-Streiff syndrome (also known as oculomandibulofacial syndrome) is a rare syndrome chiefly comprising facial and ocular abnormalities. Cataract and microphthalmos are the most apparent ocular features, but retinal abnormalities may be the primary cause of poor vision.
A 1-week-old girl of European descent was initially seen with bilateral cataracts. She was small for her 35-week gestational age. She exhibited microcephaly with birdlike facies, natal teeth, sparse fine hair, and long hyperextensible fingers consistent with features of Hallermann-Streiff syndrome (Figure 1).
This patient exhibited hypotrichosis, dyscephalia, birdlike facies, and atrophy of skin (especially on the nose), consistent with Hallermann-Streiff syndrome (also known as oculomandibulofacial syndrome).
Ophthalmologic examination revealed bilateral microphthalmia, horizontal corneal diameters of 6 mm, and bilateral visually significant cataracts preventing view of the ocular fundi. Cataract extractions were performed in this patient at 5 and 6 weeks of age. Indirect ophthalmoscopy revealed bilateral macular serous retinal detachments with horizontal retinal folds through the macula, as well as peripapillary and peripheral retinal pigment epithelial mottling (Figure 2). Treatment of uveal effusion syndrome by means of scleral surgery was considered but was declined by the parents.
Color fundus photographs (Retcam, 65° probe; Massie Research Laboratories, Pleasanton, California). A, The right fundus showed a hyperemic and hypervascular optic nerve with engorged retinal vessels. There was extensive subretinal fluid in the posterior pole, inferior retinal folds, fine yellow subretinal deposits in the papulomacular bundle, and subretinal fibrotic bands under the detached retina. Except for the posterior retinal pigment epithelium temporal to the fovea, the retinal pigment epithelium exhibited a mottled appearance. B, The left fundus had a similar appearance with less vascular engorgement and possible pigment epithelial detachment along the superotemporal vascular arcade.
Hallermann-Streiff syndrome was first described by Charles Aubry in 1893.1François2analyzed 22 cases and described 7 essential signs for what he regarded as a new syndrome linked to the various hereditary ectodermal dysplasias. These signs are (1) dyscephalia and birdlike facies, (2) dental abnormalities, (3) proportionate short stature, (4) atrophy of skin (especially on the nose), (5) hypotrichosis, (6) bilateral microphthalmos, and (7) cataract. Most cases of Hallermann-Streiff syndrome are sporadic. Autosomal dominant inheritance has been suggested in some cases.
The retinal changes we observed were strikingly similar to the original drawing of fundus abnormalities in this syndrome by François.3To our knowledge, there is no fundus photograph of a patient with Hallermann-Streiff syndrome in the English-language literature. A fluorescein angiogram (without red-free or color photography) of an exceptional case diagnosed at 11 years of age showed multiple areas of choroidal leakage.4Uveal effusion in Hallermann-Streiff syndrome may not be uncommon if these findings of chorioretinal pigmentary changes, multiple areas of choroidal leakage, and serous retinal detachment represent different manifestations of uveal effusion syndrome in these patients. Indeed, a histopathologic case series of 8 eyes with uveal effusion included a case of Hallermann-Streiff syndrome that demonstrated abnormal scleral collagen.5
Sclerectomy has been advocated for primary uveal effusion syndrome, but its efficacy in congenital uveal effusion in microphthalmic eyes is unknown. Early detection and management of retinal detachment in other patients having Hallermann-Streiff syndrome offer the chance of improved visual function.
Correspondence:Dr Adyanthaya, Zanvyl Krieger Children's Eye Center, The Wilmer Eye Institute, 600 N Wolfe St, Wilmer 233, Baltimore, MD 21287 (firstname.lastname@example.org).
Financial Disclosure:None reported.
Thank you for submitting a comment on this article. It will be reviewed by JAMA Ophthalmology editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Purchase Online Access to this article for 24 hours
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 2
Customize your page view by dragging & repositioning the boxes below.
and access these and other features:
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.